Volume 2, Issue 1, Pages 7-9 (January 2016)

Slides:

Advertisements

Similar presentations

Jeff Donovan, MD, PhD, FRCPC JAAD Case Reports

Advertisements

A case of delayed anaphylaxis after laser tattoo removal

Successful treatment of lipoatrophy with normal saline

Marc Mrad, MD, MSc, Nakhle Ayoub, MD, Ribal Mehi, MD JAAD Case Reports

Paula J. Beers, BS, Cheri N. Adgerson, MD, Susan B. Millan, MD

Volume 2, Issue 1, Pages 1-3 (January 2016)

Alopecia after injection of ATX-101 for reduction of submental fat

Hemorrhagic lesion on the chest wall after trauma

Maeve Maher, BS, Larissa Larsen, MD JAAD Case Reports

A generalized fixed drug eruption associated with mycophenolate

Volume 1, Issue 4, Pages (July 2015)

Rapid healing of chronic ulcerations and improvement in range of motion after fractional carbon dioxide (CO2) treatment after CO2 excision of hidradenitis.

Bullous pemphigoid during ustekinumab therapy

Conjunctivitis, mucosal erosions, and moist cutaneous plaques

Volume 4, Issue 1, Pages (January 2018)

Development of bullous pemphigoid during nivolumab therapy

Nail discoloration after use of hydroquinone

Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor Gabriela M. Morris, BS, Zachary P. Nahmias,

Treatment of psoriasis vulgaris using low-dose naltrexone

Is the hip prosthesis responsible for this rash?

Volume 3, Issue 2, Pages (March 2017)

Volume 3, Issue 4, Pages (July 2017)

Volume 4, Issue 10, Pages (November 2018)

Mark D. Heibel, MD, Haley D. Heibel, MS JAAD Case Reports

Nicole Leung, BS, Adela R. Cardones, MD, Nicole Larrier, MD

Successful treatment of livedoid vasculopathy with rivaroxaban

Crusted scabies in a patient with methamphetamine abuse

An erythema gyratum repens variant of bullous lupus erythematosus

Anjali Shroff, MD, Emma Guttman-Yassky, MD, PhD JAAD Case Reports

Nicole Maillet-Lebel, MD, Marie-Marthe Thibeault, MD, FRCPC

Volume 1, Issue 1, Pages 7-8 (January 2015)

Recurrent breast cellulitis from a nipple fissure

Diffuse pruritic papules

Volume 4, Issue 6, Pages (July 2018)

Pediatric psoriasis treated with apremilast

Vulvovaginal pyoderma gangrenosum in association with rituximab

Successful use of a fractional 2940-nm laser in treating chronic, severe erosive pustular dermatosis of the scalp Hailey E. Grubbs, BS, MS-IV, Chris.

Volume 3, Issue 1, Pages (January 2017)

An atypical presentation of a rare disease

Volume 3, Issue 3, Pages (May 2017)

Hemorrhagic bullae of the oral mucosa

Jennifer E. Yeh, PhD, William G. Tsiaras, MD, PhD JAAD Case Reports

Bullous pemphigoid localized in a primarily hemiplegic distribution

Eruptive neurofibromas in pregnancy

A case of delayed anaphylaxis after laser tattoo removal

Slowly progressive chest rash in an elderly woman

Balanitis associated with FOLFIRI chemotherapy

Stefan Tukaj, PhD, Detlef Zillikens, MD, Michael Kasperkiewicz, MD

Divalproex sodium: A potential therapy for scleroderma digital ulcers

Papules developing in an old tattoo

Olga Vornicova, MD, Gil Bar-Sela, MD JAAD Case Reports

Linear IgA bullous dermatosis treated with rituximab

Recalcitrant prurigo nodularis treated successfully with dupilumab

Heidrun Mitzel, MD, Stephan Grabbe, MD, Carmen Loquai, MD

Bilateral sole hyperkeratosis and nonhealing foot mass

Painful violaceus bullae of the hands

Widespread hyperpigmented rash present for 1 year

Extensive skin necrosis

Volume 5, Issue 3, Pages (March 2019)

Pembrolizumab-induced bullous pemphigoid

Volume 3, Issue 3, Pages (May 2017)

Erythema multiforme in a child with Kawasaki disease

Volume 4, Issue 1, Pages (January 2018)

Lip ulceration in an immunocompromised patient

Figurate erythema for 20 years

Bryan Baillis, MD, John C. Maize, MD JAAD Case Reports

Tattoo pigment removal by halo nevus phenomenon

Morphea in a patient undergoing treatment with ustekinumab

Comment on “Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control.

Alopecia after injection of ATX-101 for reduction of submental fat

Presentation transcript:

Volume 2, Issue 1, Pages 7-9 (January 2016) Exacerbation of bullous pemphigoid after hand, foot, and mouth disease treated with rituximab Alfreda F. Batts, BS, Sheila Z. Jalalat, MD, Lindsey Hunter-Ellul, MD, Michael G. Wilkerson, MD JAAD Case Reports Volume 2, Issue 1, Pages 7-9 (January 2016) DOI: 10.1016/j.jdcr.2015.11.006 Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Scattered erosions, crusts and tense bullae on the right superior anterolateral chest and axilla (A) and left upper arm and shoulder (B) 4 months after contracting HFMD. JAAD Case Reports 2016 2, 7-9DOI: (10.1016/j.jdcr.2015.11.006) Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

Fig 2 Postinflammatory hypopigmentation with patches of erythema and scattered milia on the left arm 6 months after initiating rituximab. JAAD Case Reports 2016 2, 7-9DOI: (10.1016/j.jdcr.2015.11.006) Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions

Fig 3 Patient's IgG BP antibody level (units) throughout course of treatment. Significant downward trending of his BP titers is noted. M, Months. JAAD Case Reports 2016 2, 7-9DOI: (10.1016/j.jdcr.2015.11.006) Copyright © 2015 American Academy of Dermatology, Inc. Terms and Conditions